Clinical Trial Update: SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia [NA]

View source ↗

Summary

The SACRED A trial, a prospective study aimed at reducing stroke in children with sickle cell disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Anemia | NA | Status: COMPLETED